D.E. Shaw & Co’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,189	Closed	-$61K	–	4598
2022 Q1	$61K	Sell	3,189 -368	-10%	-$7.04K	﹤0.01%	3841
2021 Q4	$128K	Buy	+3,557	New	+$128K	﹤0.01%	3606
2021 Q3	–	Sell	-1,111	Closed	-$155K	–	3991
2021 Q2	$155K	Buy	+1,111	New	+$155K	﹤0.01%	3284